Evaluation of Time in Therapeutic Range of Patients with Non-Valvular Atrial Fibrillation on Oral Anticoagulation with Vitamin K Antagonist in Delta Region
Mohamed Kamel Abdel Aal, Mohamed Bayoumi Nassar, Ehab Elgendy & Seham Fahmy Badr · Cardiology and Angiology: An International Journal · 2021
Background: Non-valvular atrial fibrillation (AF) is the most common cardiac arrhythmia with a prevalence as high as 1.5±2.0% in the general population. This arrhythmia remains one of the major causes of stroke, heart failure, sudden death, and cardiovascular morbidity in the wor...
Open access
Research Article
10.9734/ca/2021/v10i330172